Form 4 for TDOC Teladoc Health, Inc.
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-17 · accession 0001415889-22-005235 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-18 | 2022-05-17 | TDOC | Smith Mark Douglas | Dir | M - OptEx | — | +819 | 4,355 | +23% | — |
| D | 2022-05-18 | 2022-05-17 | TDOC | Smith Mark Douglas | Dir | M - OptEx | $0.00 | -819 | 819 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | M | A | 819 | — | 4,355 | D | — | — | (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2022-05-17 | M | D | 819 | $0.00 | 819 | D | — · — to — | 819 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. (F3) On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death. |